Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: Role in osteoblast development

Acta Diabetologica

Volumn 38, Issue 3, 2001, Pages 113-122

  McCarthy, A D ^a   Etcheverry, S B ^a   Cortizo, A M ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

Advanced glycation endproducts; Bone; Diabetes mellitus; Insulin like growth factor I; Osteoblast

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BINDING PROTEIN; BOVINE SERUM ALBUMIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BONE MINERALIZATION; BONE TISSUE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; MOUSE; NONHUMAN; OSTEOBLAST; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT;

ANIMALS; CATTLE; CELL AGING; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; GLYCOSYLATION END PRODUCTS, ADVANCED; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MICE; MINERALS; OSTEOBLASTS; RATS; SERUM ALBUMIN, BOVINE;

EID: 0035673953     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005920170007     Document Type: Article

References (51)

1. Pathogenic effects of advanced glycosylation: Biochemical, biologic and clinical implications for diabetes and ageing
2. Glycosylation non-enzymatique des protéines
3. Accelerated age-related browning of human collagen in diabetes mellitus
4. Non-enzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin
5. Changes induced by non-enzymatic glycosylation of IGF-binding protein-3: Effects on its binding properties and on its modulatory effect on IGF-I mitogenic action
6. Non-enzymatic glycosylation of alkaline phosphatase alters its biological properties
7. High-affinity receptor-mediated uptake and degradation of glucose-modified proteins: A potential mechanism for the removal of senescent macromolecules
8. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell-surface coagulant properties
9. Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodelling and diabetic nephropathy
10. Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: Regulation with stages of differentiation
11. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodelling
12. Receptor-specific induction of insulin-like growth factor-I in human monocytes by advanced glycosylation end product-modified proteins
13. Effect of diabetes mellitus on bone mass in juvenile and adult-onset diabetes
14. Diminution of bone mass in childhood diabetes
15. A prospective study of bone mass in patients with type I diabetes
16. Evaluation of bone mass and growth in young diabetics
17. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus
18. Diabetic and age-related enhancement of collagen-linked fluorescence in cortical bones of rats
19. Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia
20. Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats
21. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalised bone particles
22. Advanced glycation endproducts stimulate interleukin-6 production by human bone-derived cells
23. Nonenzymatic glycation of type I collagen modifies interaction with UMR 201-10B preosteoblastic cells
24. Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells
25. Insulin-like growth factor (IGF) and bone
26. Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue
27. Isolation of growth factors from adult bovine bone
28. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human bone
29. Stimulation of bone matrix apposition in vitro by local growth factors: A comparison between insulin-like growth factor-I, platelet-derived growth factor, and transforming growth factor
30. Insulin-like growth factor I regulates mRNA levels of osteonectin and pro-alpha l(I)-collagen in clonal preosteoblastic calvarial cells
31. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication
32. Growth factors to stimulate bone formation
33. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action
34. Growth factor modulation in insulin-like growth factor-binding proteins in rat osteoblast-like cells
35. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
36. Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs
37. Distinct proliferative and differentiated stages of murine MC3T3E1 cells in culture: An in vitro model of osteoblast development
38. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
39. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells
40. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin
41. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus
42. 18 Sep-Pak separation
43. Specificity, topography and ontogeny of the somatomedin C receptor in mammalian tissue
44. Estimation of somatomedin-C levels in normal individuals and patients with pituitary disease by immunoassay
45. Cleavage of structural protein during the assembly of the head of bacteriophage T4
46. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
47. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging
48. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through an adenosine 3′, 5′-monophosphate-dependent mechanism
49. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent
50. Changes in IGF-I and -II expression and secretion during the proliferation and differentiation of normal rat osteoblasts
51. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I